Substrate specificity of CDC2 kinase from human HeLa cells as determined with synthetic peptides and molecular modeling. 1994

J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.

A systematic study was undertaken in order to assess the substrate specificity of cyclin-B/cell division control protein kinase (CDC2) isolated from human HeLa cells, using 13-15 residue peptides with a central histone-like KKSPKK motif as a model. Replacement of the proline residue by any of the other 19 amino acids or D-proline drastically reduces or abolishes phosphorylation by CDC2. Changing the basic residues to Ala on either side of the -SP- structure differentially reduces phosphorylation. Molecular modeling and dynamics simulation indicated that the phosphorylation site of the peptide may have to adopt a turn-like conformation that will orientate the charged and hydrophobic residues so as to allow interaction with postulated binding surfaces within the CDC2 active site. It thus appears that, of the 20 coded amino acids, only proline can provide this conformation in short peptides. This is in agreement with the finding that sarcosine can replace proline in this respect (S. Ando et al. Biochem. Biophys. Res. Commun. 195, 837-843, 1993).

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
September 1990, The Journal of biological chemistry,
J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
July 1987, The Journal of biological chemistry,
J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
September 1993, Biochemical and biophysical research communications,
J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
January 2021, Methods in molecular biology (Clifton, N.J.),
J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
April 1994, European journal of biochemistry,
J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
October 1993, Biochimica et biophysica acta,
J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
August 1990, FEBS letters,
J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
March 2005, Biochimica et biophysica acta,
J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
January 1983, The Japanese journal of physiology,
J Zhang, and R J Sanchez, and S Wang, and C Guarnaccia, and A Tossi, and S Zahariev, and S Pongor
October 2000, Bioscience, biotechnology, and biochemistry,
Copied contents to your clipboard!